Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Hyeong-Cheol, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-Hyun, Choi, Ran Joo, Kim, Nam Hee, Kim, Hyun Sil, Moon, Ju Hyung, Kim, Eui Hyun, Chang, Jong Hee, Yook, Jong In, Kang, Seok-Gu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519913/
https://www.ncbi.nlm.nih.gov/pubmed/32712753
http://dx.doi.org/10.1007/s00432-020-03330-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519913/
https://www.ncbi.nlm.nih.gov/pubmed/32712753
http://dx.doi.org/10.1007/s00432-020-03330-7

Ejemplares similares